Matches in SemOpenAlex for { <https://semopenalex.org/work/W3117177153> ?p ?o ?g. }
- W3117177153 endingPage "e26089" @default.
- W3117177153 startingPage "e26089" @default.
- W3117177153 abstract "Background China is at the forefront of global efforts to develop COVID-19 vaccines and has five fast-tracked candidates at the final-stage, large-scale human clinical trials testing phase. Vaccine-promoting policymaking for public engagement is a prerequisite for social mobilization. However, making an informed and judicious choice is a dilemma for the Chinese government in the vaccine promotion context. Objective In this study, public opinions in China were analyzed via dialogues on Chinese social media, based on which Chinese netizens’ views on COVID-19 vaccines and vaccination were investigated. We also aimed to develop strategies for promoting vaccination programs in China based on an in-depth understanding of the challenges in risk communication and social mobilization. Methods We proposed a novel behavioral dynamics model, SRS/I (susceptible-reading-susceptible/immune), to analyze opinion transmission paradigms on Chinese social media. Coupled with a meta-analysis and natural language processing techniques, the emotion polarity of individual opinions was examined in their given context. Results We collected more than 1.75 million Weibo messages about COVID-19 vaccines from January to October 2020. According to the public opinion reproduction ratio (R0), the dynamic propagation of those messages can be classified into three periods: the ferment period (R01=1.1360), the revolution period (R02=2.8278), and the transmission period (R03=3.0729). Topics on COVID-19 vaccine acceptance in China include price and side effects. From September to October, Weibo users claimed that the vaccine was overpriced, making up 18.3% (n=899) of messages; 38.1% (n=81,909) of relevant topics on Weibo received likes. On the contrary, the number of messages that considered the vaccine to be reasonably priced was twice as high but received fewer likes, accounting for 25.0% (n=53,693). In addition, we obtained 441 (47.7%) positive and 295 (31.9%) negative Weibo messages about side effects. Interestingly, inactivated vaccines instigated more heated discussions than any other vaccine type. The discussions, forwards, comments, and likes associated with topics related to inactivated vaccines accounted for 53% (n=588), 42% (n=3072), 56% (n=3671), and 49% (n=17,940), respectively, of the total activity associated with the five types of vaccines in China. Conclusions Most Chinese netizens believe that the vaccine is less expensive than previously thought, while some claim they cannot afford it for their entire family. The findings demonstrate that Chinese individuals are inclined to be positive about side effects over time and are proud of China’s involvement with vaccine development. Nevertheless, they have a collective misunderstanding about inactivated vaccines, insisting that inactivated vaccines are safer than other vaccines. Reflecting on netizens’ collective responses, the unfolding determinants of COVID-19 vaccine acceptance provide illuminating benchmarks for vaccine-promoting policies." @default.
- W3117177153 created "2021-01-05" @default.
- W3117177153 creator A5014072262 @default.
- W3117177153 creator A5025315990 @default.
- W3117177153 creator A5030558698 @default.
- W3117177153 creator A5033507629 @default.
- W3117177153 creator A5044794520 @default.
- W3117177153 creator A5085383682 @default.
- W3117177153 date "2021-01-15" @default.
- W3117177153 modified "2023-10-16" @default.
- W3117177153 title "Unfolding the Determinants of COVID-19 Vaccine Acceptance in China" @default.
- W3117177153 cites W1965049702 @default.
- W3117177153 cites W1978999817 @default.
- W3117177153 cites W1980971590 @default.
- W3117177153 cites W2015376726 @default.
- W3117177153 cites W2019096529 @default.
- W3117177153 cites W2033659037 @default.
- W3117177153 cites W2046688393 @default.
- W3117177153 cites W2077109916 @default.
- W3117177153 cites W2094804567 @default.
- W3117177153 cites W2099083748 @default.
- W3117177153 cites W2117485795 @default.
- W3117177153 cites W2136601587 @default.
- W3117177153 cites W2143216598 @default.
- W3117177153 cites W2149640470 @default.
- W3117177153 cites W2172112750 @default.
- W3117177153 cites W2347191587 @default.
- W3117177153 cites W2609292553 @default.
- W3117177153 cites W2609702697 @default.
- W3117177153 cites W2761625413 @default.
- W3117177153 cites W2767326708 @default.
- W3117177153 cites W2774678941 @default.
- W3117177153 cites W2794998414 @default.
- W3117177153 cites W2883154532 @default.
- W3117177153 cites W2918535881 @default.
- W3117177153 cites W2993244320 @default.
- W3117177153 cites W3002868191 @default.
- W3117177153 cites W3004239190 @default.
- W3117177153 cites W3010571899 @default.
- W3117177153 cites W3010721747 @default.
- W3117177153 cites W3012189167 @default.
- W3117177153 cites W3013430968 @default.
- W3117177153 cites W3013458071 @default.
- W3117177153 cites W3014712943 @default.
- W3117177153 cites W3015371627 @default.
- W3117177153 cites W3016767494 @default.
- W3117177153 cites W3016989608 @default.
- W3117177153 cites W3019171825 @default.
- W3117177153 cites W3024608768 @default.
- W3117177153 cites W3025654839 @default.
- W3117177153 cites W3029097922 @default.
- W3117177153 cites W3034854384 @default.
- W3117177153 cites W3036766830 @default.
- W3117177153 cites W3037557962 @default.
- W3117177153 cites W3041663025 @default.
- W3117177153 cites W3045045932 @default.
- W3117177153 cites W3046356037 @default.
- W3117177153 cites W3048586935 @default.
- W3117177153 cites W3049044533 @default.
- W3117177153 cites W3080296106 @default.
- W3117177153 cites W3082666961 @default.
- W3117177153 cites W3083506895 @default.
- W3117177153 cites W3084273389 @default.
- W3117177153 cites W3086997971 @default.
- W3117177153 cites W3093974194 @default.
- W3117177153 cites W3098157256 @default.
- W3117177153 cites W3106644660 @default.
- W3117177153 cites W3110069439 @default.
- W3117177153 cites W3110467151 @default.
- W3117177153 cites W3112225368 @default.
- W3117177153 cites W3124367380 @default.
- W3117177153 cites W4237666176 @default.
- W3117177153 cites W4254459028 @default.
- W3117177153 cites W3099901921 @default.
- W3117177153 doi "https://doi.org/10.2196/26089" @default.
- W3117177153 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7813210" @default.
- W3117177153 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33400682" @default.
- W3117177153 hasPublicationYear "2021" @default.
- W3117177153 type Work @default.
- W3117177153 sameAs 3117177153 @default.
- W3117177153 citedByCount "72" @default.
- W3117177153 countsByYear W31171771532021 @default.
- W3117177153 countsByYear W31171771532022 @default.
- W3117177153 countsByYear W31171771532023 @default.
- W3117177153 crossrefType "journal-article" @default.
- W3117177153 hasAuthorship W3117177153A5014072262 @default.
- W3117177153 hasAuthorship W3117177153A5025315990 @default.
- W3117177153 hasAuthorship W3117177153A5030558698 @default.
- W3117177153 hasAuthorship W3117177153A5033507629 @default.
- W3117177153 hasAuthorship W3117177153A5044794520 @default.
- W3117177153 hasAuthorship W3117177153A5085383682 @default.
- W3117177153 hasBestOaLocation W31171771531 @default.
- W3117177153 hasConcept C106192422 @default.
- W3117177153 hasConcept C111472728 @default.
- W3117177153 hasConcept C134698397 @default.
- W3117177153 hasConcept C138816342 @default.
- W3117177153 hasConcept C138885662 @default.
- W3117177153 hasConcept C15744967 @default.